Bosentan 68382-0446
Product NDC
68382-0446- Manufacturer
- Zydus Pharmaceuticals Usa Inc.
- Dosage Form
- Tablet, Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA207760
Need to source Bosentan? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bosentan | 62.5 mg/1 |
Drug Class
Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A Inducers [MoA]Endothelin Receptor Antagonist [EPC]
Packaging Options(5)
100 TABLET, COATED in 1 BOTTLE (68382-446-01)
500 TABLET, COATED in 1 BOTTLE (68382-446-05)
60 TABLET, COATED in 1 BOTTLE (68382-446-14)
180 TABLET, COATED in 1 BOTTLE (68382-446-28)
10 BLISTER PACK in 1 CARTON (68382-446-77) / 10 TABLET, COATED in 1 BLISTER PACK (68382-446-30)